# OnCo record swog-s1505 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/swog-s1505/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "swog-s1505", "NCT02562716" ;
  schema:name "SWOG S1505"@en ;
  schema:alternateName "S1505"@en ;
  schema:description "SWOG S1505 gave people with operable pancreatic cancer three months of chemotherapy before and after surgery with one of the two modern regimens; about half were alive at two years with either, no better than the 40 percent threshold the trial set from adjuvant-only history, and a third of the patients enrolled turned out not to have resectable tumours on central review."@en ;
  schema:url <https://onco.cc/trials/swog-s1505/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02562716>, <https://doi.org/10.1001/jamaoncol.2020.7328> ;
  onco:status "completed" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/resectable-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/folfirinox/>, <https://onco.cc/drugs/gemcitabine-nab-paclitaxel/> ;
  onco:companies <https://onco.cc/companies/swog/> ;
  onco:terms <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/terms/resectability/> .